Other

Cost or Amortized Cost

DexCom Cost or Amortized Cost increased by 20.3% to $1.30B in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2025
Last reportedQ1 2026

How to read this metric

Changes reflect shifts in the size and composition of the fixed-income investment portfolio over time.

Detailed definition

The initial cost of debt securities adjusted for amortization of premiums or accretion of discounts, excluding unrealize...

Peer comparison

Standard accounting metric for insurance companies; peers with larger investment portfolios will show higher amortized costs.

Metric ID: other_debt_securities_available_for_sale_amortized_cost__050c1e

Historical Data

5 periods
 Q4 '24Q2 '25Q3 '25Q4 '25Q1 '26
Value$1.97B$1.77B$1.48B$1.08B$1.30B
QoQ Change-10.3%-16.1%-27.3%+20.3%
YoY Change-45.3%
Range$1.08B$1.97B
CAGR-34.2%
Avg YoY Growth-45.3%
Median YoY Growth-45.3%

Frequently Asked Questions

What is DexCom's cost or amortized cost?
DexCom (DXCM) reported cost or amortized cost of $1.30B in Q1 2026.
What does cost or amortized cost mean?
The adjusted historical cost of debt securities held for investment purposes.